WINE

OTHER NAME(S):

Alcohol, Alcool, Ethanol, Éthanol, Extrait de Vin, Red Wine, Vin, Vin Rouge, Vino, Vitis vinifera, Wine Extract.<br/><br/>

Overview

Overview Information

Wine is an alcoholic beverage prepared by fermenting grapes.

Wine is used for preventing diseases of the heart and circulatory system, including coronary heart disease, “hardening of the arteries” (atherosclerosis), heart failure, heart attack, and stroke. Wine is also used for preventing decline of thinking skills in later life, Alzheimer's disease and type 2 diabetes.

Some people use wine to reduce anxiety, stimulate the appetite, and improve digestion by increasing stomach acids.

Wine is sometimes applied directly to the skin to improve wound healing and resolve the small nodules near joints that sometimes occur with rheumatoid arthritis.

How does it work?

Wine contains ethanol (alcohol), which blocks various nerve pathways in the brain. It also contains chemicals that might have beneficial effects on the heart and blood circulation such as antioxidant effects, and preventing blood platelets from forming clots.

Uses

Uses & Effectiveness?

Likely Effective for

  • Preventing diseases of the heart and circulatory system, such as heart attack, stroke, “hardening of the arteries” (atherosclerosis), and chest pain (angina). There is some evidence that drinking alcohol can benefit the heart. Drinking one alcoholic beverage per day or drinking alcohol on at least 3 to 4 days per week is a good rule of thumb for people who drink alcohol. But don’t drink more than 2 drinks per day. More than two drinks daily can increase the risk of over-all death as well as dying from heart disease. Here is what researchers have found:
    • Drinking alcoholic beverages, including wine, by healthy people seems to reduce the risk of developing heart disease. Moderate alcohol use (one to two drinks per day) reduces the risk of coronary heart disease, atherosclerosis, and heart attack by approximately 30% to 50% when compared with nondrinkers.
    • Light to moderate alcohol (one to two drinks per day) use reduces the risk of having the type of stroke that is caused by a clot in the blood vessel (ischemic stroke), but increases the risk of having the type of stroke caused by a broken blood vessel (hemorrhagic stroke).
    • Light to moderate alcohol consumption (one to two drinks per day) in the year before a first heart attack is associated with a reduced cardiovascular and all-cause mortality risk compared with non-drinkers.
    • In men with established coronary heart disease, consumption of 1-14 alcoholic drinks per week, including wine, doesn't seem to have any effect on heart disease or all-cause mortality compared with men who drink less than one drink per week. Drinking three or more drinks per day is associated with increased likelihood of death in men with a history of heart attacks.
  • Reducing the risk of dying from heart disease and stroke and other causes. There is some evidence that light to moderate consumption of alcoholic drinks can reduce the risk of all-cause death in people who are middle-aged and older.

Possibly Effective for

  • Maintaining thinking skills with aging. Elderly men who have a history of drinking one alcoholic drink per day seem to maintain better general thinking ability during their late 70s and 80s compared to non-drinkers. However, drinking more than four alcoholic drinks per day during middle age seems to be linked with significantly poorer thinking ability later in life.
  • Preventing congestive heart failure (CHF). There is some evidence that consuming one to four alcoholic drinks per day reduces the risk of heart failure in people aged 65 years or older.
  • Preventing diabetes (type 2) and heart disease in people with diabetes. People who drink alcohol, including wine, in moderate amounts seem to have a lower risk of developing type 2 diabetes. People with diabetes who consume alcohol in moderate amounts seem to have a reduced risk of coronary heart disease compared with non-drinkers with type 2 diabetes. The risk reduction is similar to that found in healthy people who consume light to moderate amounts of alcohol.
  • Preventing ulcers caused by a bacterium called Helicobacter pylori. There is some evidence that moderate to high consumption of alcohol (more than 75 grams) per week from beverages such as beer and wine can reduce the risk of H. pylori infection.

Insufficient Evidence for

  • Preventing Alzheimer's disease. There is some evidence that 1 to 2 drinks per day can reduce the risk of developing Alzheimer's disease in both men and women compared with non-drinkers.
  • Weak bones (osteoporosis). There is some developing evidence that suggests moderate alcohol consumption in women who have passed menopause is linked with stronger bones. Alcohol intake of one-half to one drink per day seems to have the greatest effect on bone strength compared with non-drinkers and heavy drinkers of alcohol.
  • Reducing the risk of cancer. There is some developing evidence that drinking up to 21 alcoholic drinks per week, including wine, might slightly reduce the risk of cancer-related mortality.
  • Anxiety. The effect of alcohol on anxiety is complicated and may be affected by the psychological state of the user. Alcohol sometimes reduces anxiety, sometimes increases it, and sometimes has no effect.
  • Treating wounds.
  • Treating ulcers.
  • Other conditions.
More evidence is needed to rate the effectiveness of wine for these uses.

Side Effects

Side Effects & Safety

Wine is LIKELY SAFE for most adults when no more than 2 five-ounce glasses are drunk per day. Avoid higher amounts. Larger amounts can cause flushing, confusion, blackouts, trouble walking, seizures, vomiting, diarrhea, and other serious problems.

Long-term use of large amounts of wine causes many serious health problems including dependence, mental problems, heart problems, liver problems, pancreas problems, and certain types of cancer.

Special Precautions & Warnings:

Pregnancy and breast-feeding: Alcohol is UNSAFE to drink during pregnancy. It can cause birth defects and other serious harm to the unborn infant. Drinking alcohol during pregnancy, especially during the first two months, is associated with significant risk of miscarriage, fetal alcohol syndrome, as well as developmental and behavioral disorders after birth. Don’t drink alcohol if you are pregnant.

Don’t drink alcohol if you are breast-feeding. Alcohol passes into breast milk and can cause abnormal development of skills that involve both mental and muscular coordination, such as the ability to turn over. Alcohol can also disturb the infant’s sleep pattern. Alcohol also seems to reduce milk production.

Asthma: Drinking wine has been linked with triggering asthma attacks. This may be due to salicylates in the wine and/or nitrites that have been added.

Gout: Using alcohol can make gout worse.

Heart conditions: While there is some evidence that drinking wine in moderation might help to prevent congestive heart failure, wine is harmful when used by someone who already has this condition. Using alcohol can make chest pain and congestive heart failure worse.

High blood pressure: Drinking three or more alcoholic drinks per day can increase blood pressure and make high blood pressure worse.

High levels of blood fats called triglycerides (hypertriglyceridemia): Drinking alcohol can make this condition worse.

Trouble sleeping (insomnia): Drinking alcohol can make insomnia worse.

Liver disease: Drinking alcohol can make liver disease worse.

Neurological conditions: Drinking alcohol can make certain disorders of the nervous system worse.

A condition of the pancreas called pancreatitis: Drinking alcohol can make pancreatitis worse.

Stomach ulcers or a type of heartburn called gastroesophageal reflux disease (GERD): Drinking alcohol can make these conditions worse.

A blood condition called porphyria: Alcohol use can make porphyria worse.

Mental problems: Drinking three or more drinks of alcohol per day can make mental problems worse and reduce thinking skills.

Surgery: Wine can slow down the central nervous system. There is a concern that combining wine with anesthesia and other medications used during and after surgery might slow the central nervous system down too much. Stop drinking wine at least 2 weeks before a scheduled surgery.

Interactions

Interactions?

Major Interaction

Do not take this combination

!
  • Chlorpropamide (Diabinese) interacts with WINE

    The body breaks down the alcohol in wine to get rid of it. Chlorpropamide (Diabinese) might decrease how quickly the body breaks down alcohol. Drinking wine and taking chlorpropamide (Diabinese) might cause a headache, vomiting, flushing, and other unpleasant reactions. Don't drink wine if you are taking chlorpropamide (Diabinese).

  • Cisapride (Propulsid) interacts with WINE

    Cisapride (Propulsid) might decrease how quickly the body gets rid of the alcohol in wine. Taking cisapride (Propulsid) along with wine might increase the effects and side effects of alcohol.

  • Cyclosporine (Neoral, Sandimmune) interacts with WINE

    Wine might increase how much cyclosporine (Neoral, Sandimmune) the body absorbs. Taking wine along with cyclosporine (Neoral, Sandimmune) might increase the side effects of cyclosporine.

  • Disulfiram (Antabuse) interacts with WINE

    The body breaks down the alcohol in wine to get rid of it. Disulfiram (Antabuse) decreases how quickly the body breaks down alcohol. Drinking wine and taking disulfiram (Antabuse) can cause a pounding headache, vomiting, flushing, and other unpleasant reactions. Don't drink any alcohol if you are taking disulfiram (Antabuse).

  • Felodipine (Plendil) interacts with WINE

    Red wine can change the way the body absorbs and breaks down felodipine. Drinking red wine while taking felodipine for high blood pressure might cause your blood pressure to go too low.

  • Medications for depression (MAOIs) interacts with WINE

    Wine contains a chemical called tyramine. Large amounts of tyramine can cause high blood pressure. But the body naturally breaks down tyramine to get rid of it. This usually prevents the tyramine from causing high blood pressure. Some medications used for depression stop the body from breaking down tyramine. This can cause there to be too much tyramine and lead to dangerously high blood pressure. <br><nb>Some of these medications used for depression include phenelzine (Nardil), tranylcypromine (Parnate), and others.

  • Medications for pain (Narcotic drugs) interacts with WINE

    The body breaks down some medications for pain to get rid of them. The alcohol in wine might decrease how quickly the body gets rid of some medications for pain. Taking some medications for pain along with wine might increase the effects and side effects of some medications for pain.<br><nb>Some medications for pain include meperidine (Demerol), hydrocodone, morphine, OxyContin, and many others.

  • Medications that can harm the liver (Hepatotoxic drugs) interacts with WINE

    The alcohol in wine can harm the liver. Drinking wine along with medication that can harm the liver can increase the risk of liver damage. Do not drink wine if you are taking a medication that can harm the liver.<br><nb>Some medications that can harm the liver include acetaminophen (Tylenol and others), amiodarone (Cordarone), carbamazepine (Tegretol), isoniazid (INH), methotrexate (Rheumatrex), methyldopa (Aldomet), fluconazole (Diflucan), itraconazole (Sporanox), erythromycin (Erythrocin, Ilosone, others), phenytoin (Dilantin) , lovastatin (Mevacor), pravastatin (Pravachol), simvastatin (Zocor), and many others.

  • Metformin (Glucophage) interacts with WINE

    Metformin (Glucophage) is broken down by the body in the liver. The alcohol in wine is also broken down in the body by the liver. Drinking wine and taking metformin (Glucophage) might cause serious side effects.

  • Metronidazole (Flagyl) interacts with WINE

    The alcohol in wine can interact with metronidazole (Flagyl). This can lead to upset stomach, vomiting, sweating, headache, and an increased heartbeat. Do not drink wine while taking metronidazole (Flagyl).

  • Phenytoin (Dilantin) interacts with WINE

    The body breaks down phenytoin (Dilantin) to get rid of it. The alcohol in wine might increase how quickly the body breaks down phenytoin (Dilantin). Drinking wine and taking phenytoin (Dilantin) might decrease the effectiveness of phenytoin (Dilantin) and increase the possibility of seizures.

  • Sedative medications (Barbiturates) interacts with WINE

    The alcohol in wine might cause sleepiness and drowsiness. Medications that cause sleepiness and drowsiness are called sedative medications. Taking wine along with sedative medications might cause too much sleepiness. Do not drink wine if you are taking sedative medications.

  • Sedative medications (Benzodiazepines) interacts with WINE

    The alcohol in wine might cause sleepiness and drowsiness. Medications that cause sleepiness and drowsiness are called sedative medications. Taking wine along with sedative medications might cause too much sleepiness. Do not drink wine if you are taking sedative medications.<br><nb>Some of these sedative medications include clonazepam (Klonopin), diazepam (Valium), lorazepam (Ativan), and others.

  • Sedative medications (CNS depressants) interacts with WINE

    The alcohol in wine might cause sleepiness and drowsiness. Medications that cause sleepiness and drowsiness are called sedative medications. Drinking wine and taking sedative medications might cause too much sleepiness and other serious side effects.<br><nb>Some sedative medications include clonazepam (Klonopin), lorazepam (Ativan), phenobarbital (Donnatal), zolpidem (Ambien), and others.

Moderate Interaction

Be cautious with this combination

!
  • Antibiotics (Sulfonamide antibiotics) interacts with WINE

    The alcohol in wine can interact with some antibiotics. This can lead to upset stomach, vomiting, sweating, headache, and an increased heartbeat. Do not drink wine while taking antibiotics.<br><nb>Some antibiotics that interact with wine include sulfamethoxazole (Gantanol), sulfasalazine (Azulfidine), sulfisoxazole (Gantrisin), trimethoprim/sulfamethoxazole (Bactrim, Septra), and others.

  • Aspirin interacts with WINE

    Aspirin can sometimes damage the stomach and cause ulcers and bleeding. The alcohol in wine can also damage the stomach. Taking aspirin along with wine might increase the chance of ulcers and bleeding in the stomach. Avoid taking wine and aspirin together.

  • Cefamandole (Mandol) interacts with WINE

    The alcohol in wine can interact with cefamandole (Mandol). This can lead to upset stomach, vomiting, sweating, headache, and an increased heartbeat. Do not drink wine while taking cefamandole (Mandol).

  • Cefoperazone (Cefobid) interacts with WINE

    The alcohol in wine can interact with cefoperazone (Cefobid). This can lead to upset stomach, vomiting, sweating, headache, and an increased heartbeat. Do not drink wine while taking cefoperazone (Cefobid).

  • Erythromycin interacts with WINE

    The body breaks down the alcohol in wine to get rid of it. Erythromycin can decrease how quickly the body gets rid of alcohol. Drinking wine and taking erythromycin might increase the effects and side effects of alcohol.

  • Griseofulvin (Fulvicin) interacts with WINE

    The body breaks down the alcohol in wine to get rid of it. Griseofulvin (Fulvicin) decreases how quickly the body breaks down alcohol. Drinking wine and taking griseofulvin can cause a pounding headache, vomiting, flushing, and other unpleasant reactions. Don't drink any alcohol if you are taking griseofulvin.

  • Medications that decrease stomach acid (H2-Blockers) interacts with WINE

    Some medications that decrease stomach acid might interact with the alcohol in wine. Drinking wine with some medications that decrease stomach acid might increase how much alcohol the body absorbs, and increase the risk of side effects of alcohol.<br><nb>Some medications that decrease stomach acid and might interact with alcohol include cimetidine (Tagamet), ranitidine (Zantac), nizatidine (Axid), and famotidine (Pepcid).

  • NSAIDs (Nonsteroidal anti-inflammatory drugs) interacts with WINE

    NSAIDs are anti-inflammatory medications used for decreasing pain and swelling. NSAIDs can sometimes damage the stomach and intestines and cause ulcers and bleeding. The alcohol in wine can also damage the stomach and intestines. Taking NSAIDs along with wine might increase the chance of ulcers and bleeding in the stomach and intestines. Avoid taking wine and NSAIDs together.<br><nb>Some NSAIDs include ibuprofen (Advil, Motrin, Nuprin, others), indomethacin (Indocin), naproxen (Aleve, Anaprox, Naprelan, Naprosyn), piroxicam (Feldene), aspirin, and others.

  • Tolbutamide (Orinase) interacts with WINE

    The body breaks down the alcohol in wine to get rid of it. Tolbutamide (Orinase) can decrease how quickly the body breaks down alcohol. Drinking wine and taking tolbutamide (Orinase) can cause pounding headache, vomiting, flushing, and other unpleasant reactions. Don't drink wine if you are taking tolbutamide (Orinase).

  • Warfarin (Coumadin) interacts with WINE

    Warfarin (Coumadin) is used to slow blood clotting. The alcohol in wine can interact with warfarin (Coumadin). Drinking large amounts of alcohol can change the effectiveness of warfarin (Coumadin). Be sure to have your blood checked regularly. The dose of your warfarin (Coumadin) might need to be changed.

Dosing

Dosing

Alcohol intake is often measured in number of "drinks." One drink is equivalent to a 4 oz or a 120 mL glass of wine, 12 oz of beer, or 1 oz of spirits.

The following doses have been studied in scientific research:

BY MOUTH:

  • For reducing the risk of heart disease and stroke: 1-2 drinks (120-240 mL) per day.
  • For reducing the risk of heart failure: up to four drinks of wine per day.
  • For reducing loss of thinking skills in older men: up to one drink per day.
  • For reducing the risk of type 2 diabetes in healthy men: between two drinks per week and three or four drinks per day.
  • For reducing the risk of heart disease in people with type 2 diabetes: up to seven drinks per week.
  • For reducing the risk of infection with the ulcer-causing bacteria called Helicobacter pylori: more than 75 grams of alcohol from beverages such as wine.

View References

REFERENCES:

  • Abramson JL, Williams SA, Krumholz HM, Vaccarino V. Moderate alcohol consumption and risk of heart failure among older persons. JAMA 2001;285:1971-7. View abstract.
  • Ajani UA, Gaziano JM, Lotufo PA, et al. Alcohol consumption and risk of coronary heart disease by diabetes status. Circulation 2000;102:500-5. View abstract.
  • Ajani UA, Hennekens CH, Spelsberg, A, et al. Alcohol consumption and risk of type 2 diabetes mellitus among US male physicians. Arch Intern Med 2000;160:1025-30. View abstract.
  • Baer DJ, Judd JT, Clevidence BA, et al. Moderate alcohol consumption lowers risk factors for cardiovascular disease in postmenopausal women fed a controlled diet. Am J Clin Nutr 2002;75:593-9. View abstract.
  • Bailey DG, Dresser GK, Bend JR. Bergamottin, lime juice, and red wine as inhibitors of cytochrome P450 3A4 activity: comparison with grapefruit juice. Clin Pharmacol Ther 2003;73:529-37. View abstract.
  • Berger K, Ajani UA, Kase CS, et al. Light-to-moderate alcohol consumption and risk of stroke among US male physicians. N Engl J Med 1999;341:1557-64. View abstract.
  • Bobak M, Skodova Z, Marmot M. Beer and obesity: a cross-sectional study. Eur J Clin Nutr 2003;57:1250-53. View abstract.
  • Boffetta P, Garfinkel L. Alcohol drinking and mortality among men enrolled in an American Cancer Society prospective study. Epidemiology 1990;1:342-8. View abstract.
  • Bosetti C, La Vecchia C, Negri E, Franceschi S. Wine and other types of alcoholic beverages and the risk of esophageal cancer. Eur J Clin Nutr 2000;54:918-20. View abstract.
  • Bosetti C, La Vecchia C, Negri E, Franceschi S. Wine and other types of alcoholic beverages and the risk of esophageal cancer. Eur J Clin Nutr 2000;54:918-20. View abstract.
  • Brenner H, Rothenbacher D, Bode G, Adler G. Relation of smoking and alcohol and coffee consumption to active Helicobacter pylori infection: cross sectional study. BMJ 1997;315:1489-92. View abstract.
  • Burnham TH, ed. Drug Facts and Comparisons, Updated Monthly. Facts and Comparisons, St. Louis, MO.
  • Caccetta RA, Croft KD, Beilin LJ, Puddey IB. Ingestion of red wine significantly increases plasma phenolic acid concentrations but does not acutely affect ex vivo lipoprotein oxidizability. Am J Clin Nutr 2000;71:67-74. View abstract.
  • Caccetta RA, Croft KD, Beilin LJ, Puddey IB. Ingestion of red wine significantly increases plasma phenolic acid concentrations but does not acutely affect ex vivo lipoprotein oxidizability. Am J Clin Nutr 2000;71:67-74. View abstract.
  • Camargo CA, Stampfer MJ, Glynn RJ, et al. Moderate alcohol consumption and risk for angina pectoris or myocardial infarction in U.S. male physicians. Ann Intern Med 1997;126:372-5. View abstract.
  • Cervilla JA, Prince M, Joels S, et al. Long-term predictors of cognitive outcome in a cohort of older people with hypertension. Br J Psychiatry 2000;177:66-71. View abstract.
  • Cooper HA, Exner DV, Domanski MJ. Light-to-moderate alcohol consumption and prognosis in patients with left ventricular systolic dysfunction. J Am Coll Cardiol 2000;35:1753-9. View abstract.
  • Criqui MH. Alcohol and coronary heart disease: consistent relationship and public health implications. Clin Chim Acta 1996;246:51-7. View abstract.
  • de Boer MC, Schippers GM, van der Staak CP. Alcohol and social anxiety in women and men: pharmacological and expectancy effects. Addict Behav 1993;18:117-26. View abstract.
  • de Vries JH, Hollman PC, van Amersfoort I, et al. Red wine is a poor source of bioavailable flavonols in men. J Nutr 2001;131:745-8. View abstract.
  • Departments of Health and Human Services and Agriculture. Dietary Guidelines for Americans, 5th edition. Available at: http://www.health.gov/dietaryguidelines/ dga2000/document/choose.htm#alcohol
  • Di Castelnuovo A, Rotondo S, Iacoviello L, et al. Meta-analysis of wine and beer consumption in relation to vascular risk. Circulation 2002;105:2836-44.. View abstract.
  • Dufour MC. If you drink alcoholic beverages do so in moderation: what does this mean? J Nutr 2001;131:552S-61S. View abstract.
  • Duncan BB, Chambless LE, Schmidt MI, et al. Association of the waist-to-hip ratio is different with wine than with beer or hard liquor consumption. Am J Epidemiol 1995;142:1034-8. View abstract.
  • Durak I, Burak Cimen MY, Buyukkocak S, et al. The effect of red wine on blood antioxidant potential. Curr Med Res Opin 1999;15:208-13. View abstract.
  • Estruch R, Sacanella E, Badia E, et al. Different effects of red wine and gin consumption on inflammatory biomarkers of atherosclerosis: a prospective randomized crossover trial. Effects of wine on inflammatory markers. Atherosclerosis 2004;175:117-23. . View abstract.
  • Feskanich D, Korrick SA, Greenspan SL, et al. Moderate alcohol consumption and bone density among postmenopausal women. J Womens Health 1999;8:65-73. View abstract.
  • Fraser AG. Pharmacokinetic interactions between alcohol and other drugs. Clin Pharmacokinet 1997;33:79-90. View abstract.
  • Friedman LA, Kimball AW. Coronary heart disease mortality and alcohol consumption in Framingham. Am J Epidemiol 1986;124:481-9. View abstract.
  • Galanis DJ, Joseph C, Masaki KH, et al. A longitudinal study of drinking and cognitive performance in elderly Japanese American men: the Honolulu-Asia aging study. Am J Publ Health 2000;90:1254-9. View abstract.
  • Ganry O, Baudoin C, Fardellone P. Effect of alcohol intake on bone mineral density in elderly women. Am J Epidemiol 2000;151:773-80. View abstract.
  • Gaziano JM, Buring JE, Breslow JL, et al. Moderate alcohol intake, increased levels of high-density lipoprotein and its subfractions, and decreased risk of myocardial infarction. N Engl J Med 1993;329:1829-34. View abstract.
  • Goldberg I, Mosca L, Piano MR, Fisher EA. AHA Science Advisory: Wine and your heart: a science advisory for healthcare professionals from the Nutrition Committee, Council on Epidemiology and Prevention, and Council on Cardiovascular Nursing of the American Heart Association. Circulation 2001;103:472-5. View abstract.
  • Gorinstein S, Zemser M, Berliner M, Lohmann-Matthes ML. Moderate beer consumption and positive biochemical changes in patients with coronary atherosclerosis. J Intern Med 1997;242:219-24. View abstract.
  • Gronbaek M, Becker U, Johnasen D, et al. Type of alcohol consumed and mortality from all causes, coronary heart disease, and cancer. Ann Int Med 2000;133:411-9. View abstract.
  • Hart CL, Smith GD, Hole DJ, Hawthorne VM. Alcohol consumption and mortality from all causes, coronary heart disease, and stroke: results from a prospective cohort study of Scottish men with 21 years of follow up. BMJ 1999;318:1725-9. View abstract.
  • Hennekens CH, Willett W, Rosner B, et al. Effects of beer, wine, and liquor in coronary deaths. JAMA 1979;242:1973-4. View abstract.
  • Isselbacher KJ, Braunwald E, Wilson JD, et al. Harrison's Principles of Internal Medicine. 13th Ed. New York, NY: McGraw-Hill, 1994.
  • Kannel WB, Ellison RC. Alcohol and coronary heart disease: the evidence for a protective effect. Clin Chim Acta 1996;246:59-76. View abstract.
  • Kato H, Yoshikawa M, Miyazaki T, et al. Expression of p53 protein related to smoking and alcoholic beverage drinking habits in patients with esophageal cancers. Cancer Lett 2001;167:65-72. View abstract.
  • Kiechl S, Willeit J, Rungger G, et al. Alcohol consumption and atherosclerosis: what is the relation? Prospective results from the Bruneck Study. Stroke 1998;29:900-7. View abstract.
  • Klatsky AL, Armstrong MA, Friedman GD. Red wine, white wine, liquor, beer, and risk for coronary artery disease hospitalization. Am J Cardiol 1997;80:416-20. View abstract.
  • Klatsky AL. Should patients with heart disease drink alcohol. JAMA 2001;285:2004-6. View abstract.
  • Koehler KM, Baumgartner RN, Garry PJ, et al. Association of folate intake and serum homocysteine in elderly persons according to vitamin supplementation and alcohol use. Am J Clin Nutr 2001;73:628-37. View abstract.
  • Koh-Banerjee P, Chu N, Spiegelman D, et al. Prospective study of the association of changes in dietary intake, physicial activity, alcohol consumption, and smoking with 9-y gain in waist circumference among 16 587 US men. Am J Clin Nutr 2003;78:719-27.. View abstract.
  • Langer RD, Criqui MH, Reed DM. Lipoproteins and blood pressure as biological pathways for effect of moderate alcohol consumption on coronary heart disease. Circulation 1992;85:910-5. View abstract.
  • Law M, Wald N. Why heart disease mortality is low in France: the time lag explanation. BMJ 1999;318:1471-80. View abstract.
  • Leighton F, Cuevas A, Guasch V, et al. Plasma polyphenols and antioxidants, oxidative DNA damage and endothelial function in a diet and wine intervention study in humans. Drugs Exp Clin Res 1999;25:133-41. View abstract.
  • Liu Y, Tanaka H, Sasazuki S, et al. Alcohol consumption and severity of angiographically determined coronary artery disease in Japanese men and women. Atherosclerosis 2001;156:177-83. View abstract.
  • Malarcher AM, Giles WH, Croft JB, et al. Alcohol intake, type of beverage, and the risk of cerebral infarction in young women. Stroke 2001;32:77-83. View abstract.
  • Mennella J. Alcohol's effect on lactation. Alcohol Res Health 2001;25:230-4. View abstract.
  • Michaud DS, Giovannucci E, Willett WC, et al. Coffee and alcohol consumption and risk of pancreatic cancer in two prospective United States cohorts. Cancer Epidemiol Biomarkers Prev 2001;10:429-37. View abstract.
  • Mukamal KJ, Conigrave KM, Mittleman MA, et al. Roles of drinking pattern and type of alcohol consumed in coronary heart disease in men. N Engl J Med 2003;348:109-18. View abstract.
  • Mukamal KJ, Longstreth WT, Mittleman MA. Alcohol consumption and subclinical findings on magnetic resonance imaging of the brain in older adults: the cardiovascular health study. Stroke 2001;32:1939-46. View abstract.
  • Mukamal KJ, Maclure M, Muller JE, et al. Prior alcohol consumption and mortality following acute myocardial infarction. JAMA 2001:285:1965-70. View abstract.
  • Mukherjee S, Sorrell MF. Effects of alcohol consumption on bone metabolism in elderly women. Am J Clin Nutr 2000;72:1073. View abstract.
  • Offman EM, Freeman DJ, Dresser GK, et al. Cisapride interaction with grapefruit juice and red wine. Clin Pharmacol Ther 2000;67:110 (abstract PI-83).
  • Pace-Asciak CR, Rounova O, Hahn SE, et al. Wines and grape juices as modulators of platelet aggregation in healthy human subjects. Clin Chim Acta 1996;246:163-82. View abstract.
  • Pearson TA. Alcohol and heart disease. Circulation 1996;94:3023-5. View abstract.
  • Pearson TA. What to advise patients about drinking alcohol. The clinician's conundrum. JAMA 1994;272:967-8.
  • Pennell MM. One to two drinks a day may reduce risk of Alzheimer dementia. Reuters Health. www.medscape.com/reuters/prof/2000/07/07.11/20000711epid005.html (Accessed 11 July 2000).
  • Rapuri PB, Gallagher JC, Balhorn KE, Ryschon KL. Alcohol intake and bone metabolism in elderly women. Am J Clin Nutr 2000;72:1206-13. View abstract.
  • Rehm JT, Bondy SJ, Sempos CT, Vuong CV. Alcohol consumption and coronary heart disease morbidity and mortality. Am J Epidemiol 1997;146:495-501. View abstract.
  • Renaud SC, Gueguen R, Siest G, Salamon R. Wine, beer, and mortality in middle-aged men from eastern France. Arch Intern Med 1999;159:1865-70. View abstract.
  • Renaud SC, Ruf JC. Effects of alcohol on platelet functions. Clin Chim Acta 1996;246:77-89. View abstract.
  • Ridker PM, Vaughan DE, Stampfer MJ, et al. Association of moderate alcohol consumption and plasma concentration of endogenous tissue-type plasminogen activator. JAMA 1994;272:929-33. View abstract.
  • Rimm EB, Chan J, Stampfer MJ, et al. Prospective study of cigarette smoking, alcohol use and the risk of diabetes in men. Br Med J 1995;310:555-9. View abstract.
  • Rimm EB, Stampfer MJ. Wine, beer, and spirits: are they really horses of a different color? Circulation 2002;105:2806-7. View abstract.
  • Sacco RL, Elkind M, Boden-Albala B, et al. The protective effect of moderate alcohol consumption on ischemic stroke. JAMA 1999;281:53-60. View abstract.
  • Sesso HD, Stampfer MJ, Rosner B, et al. Seven-year changes in alcohol consumption and subsequent risk of cardiovascular disease in men. Arch Intern Med 2000;160:2605-12. View abstract.
  • Shaper AG, Wannamethee SG. Alcohol intake and mortality in middle aged men with diagnosed coronary heart disease. Heart 2000;83:394-9. View abstract.
  • Singletary KW, Gapstur SM. Alcohol and breast cancer: review of epidemiologic and experimental evidence and potential mechanisms. JAMA 2001;286:2143-51. View abstract.
  • Soleas GJ, Diamandis EP, Goldberg DM. Resveratrol: a molecule whose time has come? And gone? Clin Biochem 1997;30:91-113. View abstract.
  • Soleas GJ, Diamandis EP, Goldberg DM. Wine as a biological fluid: history, production, and role in disease prevention. J Clin Lab Anal 1997;11:287-313. View abstract.
  • Solomon CG, Hu FB, Stampfer MJ, et al. Moderate alcohol consumption and risk of coronary heart disease among women with type 2 diabetes mellitus. Circulation 2000;102:494-9. View abstract.
  • Stampfer MJ, Colditz GA, Willett WC, et al. A prospective study of moderate alcohol consumption and the risk of coronary disease and stroke in women. N Engl J Med 1988;319:267-73. View abstract.
  • Thadhani R, Camargo CA, Stampfer MJ, et al. Prospective study of moderate alcohol consumption and risk of hypertension in young women. Arch Intern Med 2002;162:569-74. View abstract.
  • Thun MJ, Peto R, Lopez AD, et al. Alcohol consumption and mortality among middle-aged and elderly US adults. N Engl J Med 1997;337:1705-14. View abstract.
  • Truelsen T, Gronbaek M, Schnohr P, et al. Intake of beer, wine, and spirits and risk of stroke: the copenhagen city heart study. Stroke 1998;29:2467-72. View abstract.
  • Tsunoda SM, Christians U, Velez RL, et al. Red wine (RW) effects on cyclosporine (CyA) metabolites. Clin Pharmacol Ther 2000;67:150 (abstract PIII-35).
  • Tsunoda SM, Harris RZ, Christians U, et al. Red wine decreases cyclosporine bioavailabity. Clin Pharmacol Ther 2001;70:462-7. View abstract.
  • Tsunoda SM, Harris RZ, Velez RL, et al. Red wine (RW) effects on cyclosporine (CyA) Pharmacokinetics. Clin Pharmacol Ther 1998;65:159 (abstract PII-51).
  • Vally H, de Klerk N, Thompson PJ. Alcoholic drinks: important triggers for asthma. J Allergy Clin Immunol 2000;105:462-7. View abstract.

More Resources for WINE

CONDITIONS OF USE AND IMPORTANT INFORMATION: This information is meant to supplement, not replace advice from your doctor or healthcare provider and is not meant to cover all possible uses, precautions, interactions or adverse effects. This information may not fit your specific health circumstances. Never delay or disregard seeking professional medical advice from your doctor or other qualified health care provider because of something you have read on WebMD. You should always speak with your doctor or health care professional before you start, stop, or change any prescribed part of your health care plan or treatment and to determine what course of therapy is right for you.

This copyrighted material is provided by Natural Medicines Comprehensive Database Consumer Version. Information from this source is evidence-based and objective, and without commercial influence. For professional medical information on natural medicines, see Natural Medicines Comprehensive Database Professional Version.
© Therapeutic Research Faculty 2018.